Maternity Unit, Kumba District Hospital, Kumba, Southwest Province, Cameroon ; Department of Surgery, Duke University, Durham, North Carolina, United States of America.
PLoS One. 2013 Sep 12;8(9):e72712. doi: 10.1371/journal.pone.0072712. eCollection 2013.
Although the importance of the Pap smear in reducing cancer incidence and mortality is known, many countries in Africa have not initiated yet widespread national cervical cancer screening programs. The World Health Organization (WHO) has published Clinical Practice Guidelines (CPGs) on cervical cancer screening in developing countries; however, there is a gap between expectations and clinical performance. Thus, the aim of this study was to conduct a systematic review and meta-summary to identify factors affecting compliance with CPGs for Pap screening among healthcare providers in Africa.
And Findings: MEDLINE, Scirus, Opengate and EMBASE databases were searched in January 2012. Studies involving medical personnel practicing in Africa, whose outcome measured any factors that affect medical personnel from using a Pap smear to screen for cervical cancer, were included. Two reviewers independently evaluated titles and abstracts, then full-texts, extracted data and assessed quality of the included studies. A descriptive analysis of the included studies was conducted. We calculated Frequency effect sizes (FES) for each finding and Intensity effect sizes (IES) for each article to represent their magnitudes in the analyses. Of 1011 studies retrieved, 11 studies were included (2045 individuals). Six different themes related to the factors affecting compliance with CPGs were identified: Insufficient Knowledge/Lack of awareness (FES = 82%), Negligence/Misbeliefs (FES = 82%), Psychological Reasons (FES = 73%), Time/Cost Constraint (FES = 36%), Insufficient infrastructure/training (FES = 45%) and also no reason given (FES = 36%). IES for articles ranged between 33 and 83%.
These results suggest that prevention initiatives should be comprehensive to include education and resources needs assessments and improvement, Pap smear test training, strategies on costing, and practitioner time studies.
尽管巴氏涂片在降低癌症发病率和死亡率方面的重要性已为人所知,但非洲许多国家尚未启动广泛的国家宫颈癌筛查计划。世界卫生组织(WHO)已发布了发展中国家宫颈癌筛查临床实践指南(CPGs);然而,期望与临床表现之间存在差距。因此,本研究旨在进行系统评价和荟萃分析,以确定影响非洲医疗保健提供者遵守巴氏涂片筛查 CPG 的因素。
我们于 2012 年 1 月在 MEDLINE、Scirus、Opengate 和 EMBASE 数据库中进行了搜索。纳入的研究涉及在非洲执业的医务人员,其结果衡量了任何影响医务人员使用巴氏涂片筛查宫颈癌的因素。两名审查员独立评估了标题和摘要,然后是全文,提取了数据并评估了纳入研究的质量。对纳入的研究进行了描述性分析。我们为每个发现计算了频率效应量(FES),为每个文章计算了强度效应量(IES),以表示它们在分析中的大小。在检索到的 1011 项研究中,有 11 项研究(2045 人)被纳入。确定了与遵守 CPG 相关的六个不同主题:知识不足/缺乏意识(FES = 82%)、疏忽/误解(FES = 82%)、心理原因(FES = 73%)、时间/成本限制(FES = 36%)、基础设施/培训不足(FES = 45%)以及没有给出原因(FES = 36%)。文章的 IES 范围在 33 到 83 之间。
这些结果表明,预防措施应全面,包括教育和资源需求评估和改进、巴氏涂片测试培训、成本策略以及从业者时间研究。